SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-075325
Filing Date
2008-12-08
Accepted
2008-12-08 16:15:33
Documents
5
Period of Report
2008-12-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-29973_18k.htm 8-K 43698
2 EX-3.2 a08-29973_1ex3d2.htm EX-3.2 194943
3 EX-10.1 a08-29973_1ex10d1.htm EX-10.1 38835
4 EX-99.1 a08-29973_1ex99d1.htm EX-99.1 25119
5 GRAPHIC g299731moi001.jpg GRAPHIC 3438
  Complete submission text file 0001104659-08-075325.txt   309213
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19700 | Film No.: 081236039
SIC: 2834 Pharmaceutical Preparations